Setmelanotide Imcivree Setmelanotide (preclinically known as BIM-22493, RM-493, marketed as Imcivree) is the only approved melanocortin agonist for weight loss, but is currently limited to various forms of monogenic obesity
Mochi is primarily self-pay for compounded medications, but can send brand-name prescriptions to local pharmacies for patients using insurance
These findings suggest that increased bacterial translocation may occur after exertion
If you used sterile water instead of BAC water, use the entire vial within 24-48 hours
This guide examines magnesium's role in glucose metabolism, evaluates supplement formulations for tolerability, and provides evidence-based recommendations for patients taking GLP-1 medications
Semaglutide and other GLP-1 medications are highly effective for weight management, but patients often wonder about less-discussed side effectsincluding changes to the menstrual cycle